drugset / Trial / NCT02211885
Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
Study to characterize the pharmacokinetics of 14C-radiolabeled BIRB 796 BS and its metabolites including excretion and mass balance of parent compound and radioactivity; to isolate, identify and quantify major radiolabeled metabolites of BIRB 796 in plasma, urine and feces
Timeline
- Start
- 2002-10
- Primary completion
- 2002-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIRB 796 BS | Unknown | 100 mg | Oral |
Indications
No indication recorded.